In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Rare Diseases Regulation Reimbursement

Snapshot: September Highlights

  • Analysis

Executive Summary

A selection of articles you might have missed from September 2022, including highlights from In Vivo's spotlight on rare diseases, their diagnosis and treatment.

You may also be interested in...



Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust

2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public. 

Deals Shaping The Industry, February 2024

An interactive look at pharma, medtech, and diagnostics deals made during February 2023. Data courtesy of Biomedtracker.

Execs On The Move: February 2024

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Table

View full table

Topics

Tags:
Rare Diseases Regulation Reimbursement
Latest Headlines

Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking

UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024

Deals in Depth: March 2024

Coming Of Age: Pharma’s Influencer Marketing Matures

See All
UsernamePublicRestriction

Register

IV146710

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By